Stage 2 · Toolkit 2.2
GLP Compliance & Sponsor Oversight
Ensure GLP studies are appropriately planned, overseen, monitored, documented, reported, and archived.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for GLP Compliance & Sponsor Oversight.
How it helps your team
Surface evidence gaps and dependencies before they delay IND, CTA, or first-in-human decisions.
Designed for
Nonclinical development, toxicology, safety pharmacology, bioanalysis, Regulatory Affairs, and Quality teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- GLP Sponsor Oversight SOP
- GLP Study Oversight Plan
- GLP Facility Qualification Checklist
- GLP Study Director / Sponsor Interface Guide
- GLP Deviation Review Form
- GLP Archive Transfer Checklist
- GLP Evidence Review Checklist
Excel workbooks
- GLP Study Tracker
- GLP Vendor / Facility Tracker
- GLP Deviation Log
- GLP Audit / QA Inspection Tracker
- GLP Evidence Matrix
- GLP Action Tracker
Related toolkits
Continue within stage 2
Nonclinical Development Plan & IND/CTA-Enabling Strategy
Define the nonclinical package needed to support IND, CTA, first-in-human, and clinical development.
2.3Toxicology Study Planning & Management
Manage toxicology studies and interpret key findings for regulatory and FIH readiness.
2.4Safety Pharmacology Program
Assess safety pharmacology risks, including cardiovascular, respiratory, and CNS risk.